NASDAQ
31.89USD
-0.27 (-0.84%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
41M
P/E
—
EPS
—
Beta
0.43
52W range
26.34-37.15
Day range
31.71–32.13
Open
31.97
Prev close
32.16
Volume
12.3K
Avg volume
21.5K
Dividend
0.41
IPO
2024-05-21
Roundhill considers weight loss medications, particularly GLP-1 agonists, to be among the most groundbreaking innovations currently reshaping the global pharmaceutical landscape. This conviction underpins the Roundhill GLP-1 & Weight Loss ETF (OZEM), which is distinguished as the world's inaugural ETF exclusively focused on the GLP-1 and broader weight management sector. Notably, OZEM employs an active management approach.
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Roundhill Investments - GLP-1 & Weight Loss ETF — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for OZEM: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
